DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Morgan Stanley - 1 Wells - 1 JPM - 1 PENN - 1 VIRT - 1 William Blair - 1 Jefferies - 1 MET's - 1
Top related locs:
Top related orgs:
Bank of America - 1 Amazon - 1 Nvidia - 1 NVIDIA - 1 JPMorgan - 1 Apple - 1 Wave7 Research - 1 Deutsche Bank - 1

Search resuls for: "Wave7 Research"


2 mentions found


☆ Here are Thursday's biggest analyst calls: Nvidia, Apple, BJ's, Etsy, Carnival, Blackrock, FedEx & more
  + stars: | 2023-09-14 | by ( Michael Bloom | ) www.cnbc.com   time to read: +6 min
Here are the biggest calls on Wall Street on Thursday: Bank of America downgrades J.M. "Our prior Buy rating was based on the view that SJM would focus on a more optimized portfolio of core brands, following several years of divestitures of low growth/margin assets. Bank of America reiterates Alphabet as buy Bank of America said it's standing by its buy rating on the stock due to "AI innovation & potentially lower expenses." Bank of America reiterates Blackrock as buy Bank of America said the company is the "leading platform for investing & tech solutions." Goldman Sachs reiterates FedEx as buy Goldman said it's standing by its buy rating heading into earnings next week.
Persons: Morgan Stanley, Wells, JPM, PENN, VIRT, William Blair, Jefferies, MET's, Semtech, Wolfe, TD Cowen, Redburn, BLK, Goldman Sachs, Goldman Organizations: Bank of America, Amazon, Nvidia, NVIDIA, JPMorgan, Apple, Wave7 Research, Deutsche Bank, Penn Deutsche, Penn, Citi, Google, BMO, Jefferies, MetLife, Susquehanna, Blackrock, FedEx
☆ Here are Wednesday's biggest analyst calls: Apple, Procter & Gamble, Tesla, Spotify, AbbVie & more
  + stars: | 2023-03-01 | by ( Michael Bloom | ) www.cnbc.com   time to read: +9 min
Morgan Stanley upgrades Sarepta to overweight from equal weight Morgan Stanley said it's bullish on the company's gene therapy drug, SRP-9001. Morgan Stanley reiterates Rivian as overweight Morgan Stanley said it's standing by its overweight rating on the EV maker after its earnings report on Tuesday, but says it's now a show-me story. Morgan Stanley reiterates Eli Lilly as top pick Morgan Stanley said the stock is best-in-class and that it's bullish on its diabetes drug, Mounjaro. Morgan Stanley names JD.com a catalyst driven idea Morgan Stanley said it's bullish heading into the China e-commerce company's earnings on March 9. Morgan Stanley reiterates Microsoft as overweight Morgan Stanley said it's standing by shares of Microsoft.
Organizations: ~$
0 next >>
Total: 2